"10.1371_journal.pone.0151362","plos one","2016-03-15T00:00:00Z","Amanda M DiNofia; Elizabeth Salazar; Alix E Seif; Yimei Li; Yuan-Shung Vera Huang; Rochelle Bagatell; Brian T Fisher; Richard Aplenc","Division of Oncology, The Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America; Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America; Center for Pediatric Clinical Effectiveness, The Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America; Division of Infectious Diseases, The Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America","Conceived and designed the experiments: AD ES RA. Performed the experiments: AD ES YL YSH. Analyzed the data: AD ES YL YSH RA. Contributed reagents/materials/analysis tools: AD ES AS YL YSH RB BF RA. Wrote the paper: AD ES AS YL YSH RB BF RA.","BF receives funding from Pfizer and Merck to support some of his research efforts. Neither Pfizer nor Merck are involved in the manufacturing of bortezomib. This relationship does not alter the authors adherence to PLOS ONE policies on sharing data and materials. There were no conflicts to report for the remaining authors.","2016","03","Amanda M DiNofia","AMDN",8,TRUE,3,4,5,8,TRUE,TRUE,FALSE,0,NA,FALSE
